pentoxiphylline

DRUG3 trials

Sponsors

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Meir Medical Center, Institute of Liver and Biliary Sciences, India

Conditions

Alcoholic HepatitisChronic Kidney Disease (CKD) HemodialysisContrast Induced NephropathyDiabetes MellitusHypoalbuminemiaInflammationOxidative StressProtein-energy Malnutrition

Phase 3

Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients

CompletedNCT00561093

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterChronic Kidney Disease (CKD) Hemodialysis, Hypoalbuminemia, Inflammation +2

Start: 2008-02-29End: 2011-05-31Updated: 2015-05-21

Unknown Phase

Renal Effect of Pentoxyphylline in High Risk Patients Undergoing Angiography

WithdrawnNCT01144091

Meir Medical CenterContrast Induced Nephropathy, Diabetes Mellitus

Start: 2012-12-31End: 2013-12-31Updated: 2015-04-08

Pentoxyphilline Versus Fecal Microbiota Therapy in Severe Alcoholic Hepatitis

CompletedNCT02458079

Institute of Liver and Biliary Sciences, IndiaAlcoholic Hepatitis

Start: 2014-12-01End: 2016-07-27Updated: 2019-08-15